Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.54 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.54 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.54 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.54 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.48 |
| ▸ | ADH1B | P00325 | 1/20 | 0.48 |
| ▸ | ADH1C | P00326 | 1/20 | 0.48 |
| ▸ | ADH1A | P07327 | 1/20 | 0.48 |
| ▸ | ADH4 | P08319 | 1/20 | 0.48 |
| ▸ | ADH7 | P40394 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10823155 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL381605 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL16389880 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL2239182 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL10607046 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL16390216 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL2242482 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL2242301 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL10822737 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 | |
| SCHEMBL6924245 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRLMNAHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025217264-A1 | CATIONIC LIPID COMPOUNDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2025-10-16 | — | — | WO | disclosed |
| US-11820728-B2 | Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids | Acuitas Therapeutics, Inc. (CA) | 2023-11-21 | — | — | US | disclosed |
| US-11639329-B2 | Lipids for use in lipid nanoparticle formulations | Acuitas Therapeutics, Inc. (CA) | 2023-05-02 | — | — | US | disclosed |
| US-10479795-B2 | Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors | INCYTE CORPORATION (US) | 2019-11-19 | — | — | US | disclosed |
| US-20190119287-A1 | HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS | INCYTE CORPORATION | 2019-04-25 | — | — | US | disclosed |
| US-20180185516-A1 | DELIVERY OF TARGET SPECIFIC NUCLEASES | Acuitas Therapeutics, Inc. (CA) | 2018-07-05 | — | — | US | disclosed |
| US-20180185516-A1 | DELIVERY OF TARGET SPECIFIC NUCLEASES | Acuitas Therapeutics, Inc. (CA) | 2018-07-05 | — | — | US | disclosed |
| WO-2018107026-A1 | DELIVERY OF TARGET SPECIFIC NUCLEASES | SANGAMO THERAPEUTICS, INC. (US) | 2018-06-14 | — | — | WO | disclosed |
| US-9803155-B2 | Lubricating oil composition, and sliding mechanism using lubricating oil composition | IDEMITSU KOSAN CO., LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9593291-B2 | Lubricating oil composition, and sliding mechanism using lubricating oil composition | IDEMITSU KOSAN CO., LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20150036962-A1 | LUBRICATING OIL COMPOSITION, AND SLIDING MECHANISM USING LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2015-02-05 | — | — | US | disclosed |
| EP-2826845-A1 | LUBRICATING OIL COMPOSITION, AND SLIDING MECHANISM USING LUBRICATING OIL COMPOSITION | Idemitsu Kosan Co., Ltd (JP) | 2015-01-21 | — | — | EP | disclosed |
| EP-2826844-A1 | LUBRICATING OIL COMPOSITION, AND SLIDING MECHANISM USING LUBRICATING OIL COMPOSITION | Idemitsu Kosan Co., Ltd (JP) | 2015-01-21 | — | — | EP | disclosed |
| EP-2705894-A1 | Acid gas absorbent, acid gas removal method and acid gas removal device | Kabushiki Kaisha Toshiba (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-20120161071-A1 | ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE | KABUSHIKI KAISHA TOSHIBA (JP) | 2012-06-28 | — | — | US | disclosed |
| EP-2468385-A2 | Acid gas absorbent, acid gas removal method and acid gas removal device | Kabushiki Kaisha Toshiba (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-0107120-B1 | SUBSTITUTED AMINOALCANOL PHOSPHOLIPIDS AND PROCESS FOR THEIR PREPARATION | A. Nattermann & Cie. GmbH (DE) | 1986-10-29 | — | — | EP | disclosed |
| US-4565659-A | Substituted aminoalkanol phospholipids | A. NATTERMANN & CIE GMBH (DE) | 1986-01-21 | — | — | US | disclosed |
| EP-0066919-B1 | 4-ALKYL-THIOPHENYL-ETHANOLAMINES, HAVING AN ACTIVITY ON THE CEREBRAL CIRCULATION, THE BLOOD PLATELET-AGGREGATION AND THE LIPEMIA | MAGGIONI FARMACEUTICI S.p.A. (IT) | 1985-03-20 | — | — | EP | disclosed |
| EP-0107120-A1 | Substituted aminoalcanol phospholipids and process for their preparation | A. Nattermann & Cie. GmbH (DE) | 1984-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479795-B2 | Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors | PIK3CG, PIK3CD, PIK3CA | ALDH1A1 1354/4885TSHR 1148/4885LMNA 3733/4885 |
| US-11820728-B2 | Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids | TTPA, ACAA2, CPT2 | ALDH1A1 207/4885TSHR 2749/4885LMNA 12/4885 |
| US-11639329-B2 | Lipids for use in lipid nanoparticle formulations | PHOSPHO1, NPC1, NPC1L1 | ALDH1A1 909/4885TSHR 2482/4885LMNA 183/4885 |
| US-20190119287-A1 | HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS | PIK3R5, PIK3CA, PIK3CD | ALDH1A1 3638/4885TSHR 2451/4885LMNA 3480/4885 |
| US-20180185516-A1 | DELIVERY OF TARGET SPECIFIC NUCLEASES | DNASE1L3, DNASE1, RNASE1 | ALDH1A1 3876/4885TSHR 2378/4885LMNA 95/4885 |
| US-20120161071-A1 | ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE | ALKBH1, ALKBH3, ALKBH2 | ALDH1A1 247/4885TSHR 1545/4885LMNA 4049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.